Imipenem/Cilastatin versus Cefepime as Empiric Monotherapy for Fever in Neutropenic Patients after ematopoietic Stem Cell Transplantation
Objective: To evaluate the potential advantages of imipenem/cilastatin in control of fever in neutro-penic HSCT recipients.Patients and Method: In this single-center study, 111 consecutive febrile episodes in 104 neutropenic HSCT recipients with a mean age of 26 years were randomized to treatment ei...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Tehran University of Medical Sciences
2005-06-01
|
| Серія: | International Journal of Hematology-Oncology and Stem Cell Research |
| Предмети: | |
| Онлайн доступ: | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/189 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|